Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT LEXICON PHARMACEUTICALS, INC.

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX)
Listen to this Section


$0.76
-0.0021 ( +1.07% ) 1.9M

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Market Data


Open $0.76
Previous Close $0.76
Volume 1.9M
Market Cap $267.58M
Day Range $0.75 - $0.78
52 Week Range $0.62 - $3.73
Shares Outstanding 361.49M
Change % +1.07%
Net Change ▼ -0.0021
Insider Ownership -0.06%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
IPO Year 2000
Country United States

Insider Ownership Transactions

Total Amount Purchased: -63,152,917.00

Date Type Amount Purchased Purchaser
2024-08-12 Sale -200000.00 Corrigan Brian
2024-07-08 Sale -1675000.00 Exton Michael
2024-07-08 Sale -307000.00 WADE JEFFREY L
2024-05-14 Sale -57546100.00 Artal International S.C.A.
2024-05-13 Sale -44906.00 LEFKOWITZ ROBERT J MD
2024-05-13 Sale -44906.00 Sullivan Diane E.
2024-05-13 Sale -44906.00 SOBECKI CHRISTOPHER J
2024-05-13 Sale -44906.00 BARKER SAM L
2024-05-13 Sale -44906.00 Swain Judith L
2024-05-13 Sale -44906.00 Amouyal Philippe

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Apr 29, 2024
8-k 8K-related 1 Apr 29, 2024
ars Annual reports 1 Mar 26, 2024
def Proxies and info statements 3 Mar 26, 2024
10-k Annual reports 72 Mar 25, 2024
4 Insider transactions 1 Mar 13, 2024
8-k 8K-related 15 Mar 12, 2024
8-k 8K-related 20 Mar 11, 2024
pre Proxies and info statements 3 Mar 11, 2024
4 Insider transactions 1 Feb 29, 2024

Latest News


× Before browsing our site, please accept our cookies policy